Cartography Biosciences
Building a smarter roadmap for precision therapeutics
- Headquarters
- South San Francisco, California
- Employees
- 11–50
- Founded
- 2020
- Website
- cartography.bio
- Total Funding
- $67.0M
- Last Round
- $67.0M Series BOct 2025
- Rounds
- 1
About
Cartography Biosciences is a therapeutics company building a differentiated pipeline of antibody-based cancer therapies designed to be more precise than existing treatments. The company uses a comprehensive antigen atlas—built from over 15 million tumor and healthy cells analyzed via single-cell sequencing—combined with antibody engineering and computational biology to identify and validate the safest, most effective oncology targets. Founded by Stanford and UCSF researchers, Cartography's platform bridges cellular genomics and drug discovery to widen the world of treatable cancers.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Oct 2025
Investors
Sign up to view investors
Create a free account to see which investors have funded this company.
Create Free AccountSimilar Companies
Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...
OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic is an AI research company that builds reliable, interpretable, and steerable AI systems.
xAI is an AI platform for accelerating human scientific discovery.
Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...
Anduril Industries is a defense technology company with a mission to transform US and allied mili...